Logo image of 1CS.MI

AXA SA (1CS.MI) Stock Fundamental Analysis

BIT:1CS - Euronext Milan - FR0000120628 - Common Stock - Currency: EUR

41.55  -0.28 (-0.67%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to 1CS. 1CS was compared to 39 industry peers in the Insurance industry. 1CS has only an average score on both its financial health and profitability. 1CS has a decent growth rate and is not valued too expensively. 1CS also has an excellent dividend rating. With these ratings, 1CS could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

1CS had positive earnings in the past year.
1CS had a positive operating cash flow in the past year.
Each year in the past 5 years 1CS has been profitable.
Each year in the past 5 years 1CS had a positive operating cash flow.
1CS.MI Yearly Net Income VS EBIT VS OCF VS FCF1CS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

1CS's Return On Assets of 1.18% is in line compared to the rest of the industry. 1CS outperforms 58.97% of its industry peers.
Looking at the Return On Equity, with a value of 15.39%, 1CS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
1CS has a Return On Invested Capital (1.33%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1CS is in line with the industry average of 2.14%.
The last Return On Invested Capital (1.33%) for 1CS is above the 3 year average (1.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROIC 1.33%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
1CS.MI Yearly ROA, ROE, ROIC1CS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

1CS has a Profit Margin (8.80%) which is comparable to the rest of the industry.
1CS's Profit Margin has improved in the last couple of years.
1CS's Operating Margin of 12.32% is in line compared to the rest of the industry. 1CS outperforms 56.41% of its industry peers.
In the last couple of years the Operating Margin of 1CS has grown nicely.
Industry RankSector Rank
OM 12.32%
PM (TTM) 8.8%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
1CS.MI Yearly Profit, Operating, Gross Margins1CS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1CS is destroying value.
Compared to 1 year ago, 1CS has less shares outstanding
Compared to 5 years ago, 1CS has less shares outstanding
1CS has a worse debt/assets ratio than last year.
1CS.MI Yearly Shares Outstanding1CS.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
1CS.MI Yearly Total Debt VS Total Assets1CS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

1CS has an Altman-Z score of 0.35. This is a bad value and indicates that 1CS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of 1CS (0.35) is better than 87.18% of its industry peers.
The Debt to FCF ratio of 1CS is 2.19, which is a good value as it means it would take 1CS, 2.19 years of fcf income to pay off all of its debts.
1CS has a better Debt to FCF ratio (2.19) than 76.92% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that 1CS is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.53, 1CS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Altman-Z 0.35
ROIC/WACC0.13
WACC10.45%
1CS.MI Yearly LT Debt VS Equity VS FCF1CS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

1CS has a Current Ratio of 0.87. This is a bad value and indicates that 1CS is not financially healthy enough and could expect problems in meeting its short term obligations.
1CS has a Current ratio of 0.87. This is amongst the best in the industry. 1CS outperforms 89.74% of its industry peers.
1CS has a Quick Ratio of 0.87. This is a bad value and indicates that 1CS is not financially healthy enough and could expect problems in meeting its short term obligations.
1CS has a better Quick ratio (0.87) than 89.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
1CS.MI Yearly Current Assets VS Current Liabilites1CS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

1CS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.08%, which is quite good.
The Earnings Per Share has been growing by 18.09% on average over the past years. This is quite good.
The Revenue has been growing slightly by 4.38% in the past year.
1CS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.16% yearly.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%

3.2 Future

Based on estimates for the next years, 1CS will show a small growth in Earnings Per Share. The EPS will grow by 5.12% on average per year.
1CS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.15% yearly.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.15%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1CS.MI Yearly Revenue VS Estimates1CS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
1CS.MI Yearly EPS VS Estimates1CS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.57, the valuation of 1CS can be described as reasonable.
71.79% of the companies in the same industry are more expensive than 1CS, based on the Price/Earnings ratio.
1CS is valuated cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 10.37, the valuation of 1CS can be described as reasonable.
Based on the Price/Forward Earnings ratio, 1CS is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.52. 1CS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.57
Fwd PE 10.37
1CS.MI Price Earnings VS Forward Price Earnings1CS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, 1CS is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.68
EV/EBITDA N/A
1CS.MI Per share data1CS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

1CS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 1CS may justify a higher PE ratio.
PEG (NY)1
PEG (5Y)0.64
EPS Next 2Y9.13%
EPS Next 3Y8.44%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.16%, 1CS is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.54, 1CS pays a bit more dividend than its industry peers.
1CS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 5.16%

5.2 History

The dividend of 1CS is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

57.97% of the earnings are spent on dividend by 1CS. This is a bit on the high side, but may be sustainable.
The dividend of 1CS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
1CS.MI Yearly Income VS Free CF VS Dividend1CS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
1CS.MI Dividend Payout.1CS.MI Dividend Payout, showing the Payout Ratio.1CS.MI Dividend Payout.PayoutRetained Earnings

AXA SA

BIT:1CS (7/17/2025, 7:00:00 PM)

41.55

-0.28 (-0.67%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)03-19 2025-03-19/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners33.99%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap92.05B
Analysts81.54
Price Target44.23 (6.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.16%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.61%
Valuation
Industry RankSector Rank
PE 11.57
Fwd PE 10.37
P/S 1.05
P/FCF 7.68
P/OCF 7.38
P/B 1.84
P/tB 3.36
EV/EBITDA N/A
EPS(TTM)3.59
EY8.64%
EPS(NY)4.01
Fwd EY9.64%
FCF(TTM)5.41
FCFY13.03%
OCF(TTM)5.63
OCFY13.54%
SpS39.42
BVpS22.54
TBVpS12.36
PEG (NY)1
PEG (5Y)0.64
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROCE 1.67%
ROIC 1.33%
ROICexc 1.37%
ROICexgc 1.79%
OM 12.32%
PM (TTM) 8.8%
GM N/A
FCFM 13.73%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.54%
Interest Coverage 1.72
Cash Conversion N/A
Profit Quality 156.03%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.35
F-Score7
WACC10.45%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.15%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%